Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.58 |
| ▸ | MPI | P34949 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | ELANE | P08246 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29728164 | 1.00 | KMT2A (0.58) | KMT2AALDH1A1KDM4EMEN1HPGD | |
| Iodide SCHEMBL30772927 | 0.98 | KMT2A (0.57) | KMT2AALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL26217310 | 0.87 | KMT2A (0.48) | KMT2AALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL17281452 | 0.83 | ELANE (0.48) | KMT2AALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL18133627 | 0.81 | ELANE (0.47) | KMT2AALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL20669007 | 0.81 | ELANE (0.47) | KMT2AALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL30773494 | 0.76 | ELANE (0.52) | KMT2AALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL29948066 | 0.76 | CYP3A4 (0.42) | KMT2AALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL18549019 | 0.76 | ELANE (0.52) | KMT2AALDH1A1KDM4EMEN1HPGD | |
| SCHEMBL2517690 | 0.76 | CYP3A4 (0.42) | KMT2AALDH1A1KDM4EMEN1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7566707-B2 | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-07-28 | — | — | US | claimed |
| EP-1641799-B1 | IMIDAZO-PYRIDAZINONE DERIVATIVES AND IMIDAZO-PYRIDONE DERIVATIVES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS | BOEHRINGER INGELHEIM INT (DE) | 2008-03-12 | — | — | EP | claimed |
| US-20050026921-A1 | New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-02-03 | — | — | US | claimed |
| US-20250312504-A1 | VOLATILE COMPOSITION DISPENSER FOR COMPOSITIONS COMPRISING A META-(C1-C4 ALKOXY) SALICYLALDEHYDE | THE PROCTER & GAMBLE COMPANY | 2025-10-09 | — | — | US | disclosed |
| US-20240401112-A1 | NOVEL COMPOUNDS AND THEIR APPLICATIONS | SFC CO., LTD. (KR) | 2024-12-05 | — | — | US | disclosed |
| US-20240199997-A1 | COMPOSITIONS COMPRISING A META-(C1-C4 ALKOXY) SALICYLALDEHYDE | PROCTER & GAMBLE COMPANY, THE | 2024-06-20 | — | — | US | disclosed |
| CN-114874153-B | Synthetic method of naphtho [2,1-d ] oxazole compound | 湖南第一师范学院 | 2023-11-17 | — | — | CN | disclosed |
| US-11737353-B2 | Plurality of host materials and organic electroluminescent device comprising the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. | 2023-08-22 | — | — | US | disclosed |
| WO-2023153739-A1 | NOVEL COMPOUND AND USES THEREOF | 에스에프씨 주식회사 | 2023-08-17 | — | — | WO | disclosed |
| US-20220209132-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | Changchun Hyperions Technology Co., Ltd. (CN) | 2022-06-30 | — | — | US | disclosed |
| EP-4006025-A1 | HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF | Changchun Hyperions Technology Co., Ltd. (CN) | 2022-06-01 | — | — | EP | disclosed |
| US-7566707-B2 | Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-07-28 | — | — | US | disclosed |
| US-7173152-B2 | One-pot reductive acetamidation of aryl nitro compounds | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2007-02-06 | — | — | US | disclosed |
| US-7173152-B2 | One-pot reductive acetamidation of aryl nitro compounds | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2007-02-06 | — | — | US | disclosed |
| US-20050026921-A1 | New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-02-03 | — | — | US | disclosed |
| US-6747159-B2 | USING CYANINE COMPOUND | VISEN MEDICAL, INC. | 2004-06-08 | — | — | US | disclosed |
| US-6610468-B2 | Naphthoxazole and thiazole derivative | FUJI PHOTO FILM CO., LTD. (JP) | 2003-08-26 | — | — | US | disclosed |
| US-20020156288-A1 | Symmetric, monofunctionalised polymethine dyes labelling reagents | VISEN MEDICAL, INC. | 2002-10-24 | — | — | US | disclosed |
| US-20020051950-A1 | Silver halide photographic material | FUJIFILM CORPORATION (JP) | 2002-05-02 | — | — | US | disclosed |
| US-4460779-A | Method for preparing 2-lower alkyl-substituted naphthoxazoles by way of non-toxic intermediates | MINNESOTA MINING & MANUFACTURING COMPANY (US) | 1984-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156288-A1 | Symmetric, monofunctionalised polymethine dyes labelling reagents | H1-0, H1-3, H1-2 | KMT2A 802/4885ALDH1A1 2182/4885KDM4E 2070/4885 |
| US-20220209132-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | EML4, STOM, GJB2 | KMT2A 1066/4885ALDH1A1 2548/4885KDM4E 1381/4885 |
| US-20050026921-A1 | New imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions | DPP4, DPP3, DPP7 | KMT2A 2813/4885ALDH1A1 239/4885KDM4E 178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.